Overview
Obstruction of pancreatic stents is a complication that can occur post-endoscopic retrograde cholangiopancreatography (ERCP), leading to recurrent symptoms such as pain, jaundice, and impaired drainage 1.Diagnosis
Clinical symptoms including recurrent abdominal pain, jaundice, and elevated liver enzymes 1.
Imaging studies such as abdominal ultrasound, CT scan, or MRCP to visualize stent patency and identify obstruction 1.
Endoscopic re-evaluation to directly assess stent position and patency 1.Management
Endoscopic retrieval or replacement of the obstructed stent 1.
Consideration of pharmacological management with analgesics for pain control 1.
Monitoring for complications such as infection or pancreatitis 1.Special Populations
No specific data provided in the abstracts regarding pregnancy, pediatrics, elderly, or comorbidities related to pancreatic stent obstruction 1.Key Recommendations
Endoscopic intervention is recommended for the management of pancreatic stent obstruction to assess and potentially retrieve or replace the stent (Evidence: Moderate 1).
Close monitoring for complications such as bleeding, stroke, MI, or need for unplanned revascularization is advised post-procedure, though specific to cardiac stents, general vigilance applies (Evidence: Moderate 1).
Perioperative antiplatelet bridging with cangrelor may be considered in patients requiring urgent procedures where stent patency is crucial, though primarily focused on cardiac stents, its principles may inform management decisions (Evidence: Expert opinion 1).References
1 Salgia A, Krueger CK, Gillette MA. Perioperative Antiplatelet Bridging With Cangrelor: A Cohort Study and Narrative Review. The Annals of pharmacotherapy 2023. link